CRP and benign prostatic hyperplasia: Serum biomarkers, such as prostate-specific arginine esterase and CRP, have been explored; however, their diagnostic performance remains inconsistent, with CRP demonstrating limited utility in distinguishing BPH from other prostatic diseases.